MEDINET Co., Ltd.
TSE:2370.T
39 (JPY) • At close July 30, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 768.501 | 661.543 | 633.672 | 683.033 | 783.035 | 1,059.021 | 998.278 | 1,704.004 | 1,909.324 | 1,674.379 | 1,843.995 | 2,110.453 | 2,190.986 | 2,674.19 | 3,202.49 | 2,900.215 |
| Cost of Revenue
| 655.808 | 563.291 | 505.748 | 502.617 | 491.659 | 658.583 | 668.267 | 934.886 | 1,048.647 | 1,001.349 | 1,018.392 | 1,084.748 | 1,038.448 | 993.962 | 1,029.184 | 881.819 |
| Gross Profit
| 112.692 | 98.252 | 127.924 | 180.416 | 291.376 | 400.438 | 330.011 | 769.118 | 860.677 | 673.03 | 825.603 | 1,025.705 | 1,152.538 | 1,680.228 | 2,173.306 | 2,018.396 |
| Gross Profit Ratio
| 0.147 | 0.149 | 0.202 | 0.264 | 0.372 | 0.378 | 0.331 | 0.451 | 0.451 | 0.402 | 0.448 | 0.486 | 0.526 | 0.628 | 0.679 | 0.696 |
| Reseach & Development Expenses
| 452.775 | 496.674 | 565.224 | 325.718 | 249.996 | 276.566 | 1,502.882 | 612.477 | 603.364 | 645 | 659 | 518 | 0.515 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,269 | 1.233 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 116 | 0.115 | 0 | 0 | 0 |
| SG&A
| 977.485 | 986.458 | 858.312 | 885.383 | 905.778 | 1,027.839 | 1,528.336 | 1,958.176 | 1,938.415 | 1,769 | 1,573 | 1,385 | 1.348 | 0 | 0 | 0 |
| Other Expenses
| 1,497.483 | 41.072 | 1,461.023 | 1,261.064 | 1,217.497 | 1,408.707 | 9.366 | -2.236 | 3.415 | -4.667 | 1.747 | -2.236 | 4.965 | 1.799 | 4.428 | 84.214 |
| Operating Expenses
| 1,497.483 | 1,524.204 | 1,461.023 | 1,261.064 | 1,217.497 | 1,408.707 | 3,031.218 | 2,570.653 | 2,541.779 | 2,414.881 | 2,232.626 | 1,903.559 | 1,863.67 | 1,983.822 | 1,839.293 | 1,724.631 |
| Operating Income
| -1,347.59 | -1,425.952 | -1,333.1 | -1,080.649 | -926.122 | -1,008.27 | -2,701.207 | -1,801.535 | -1,681.103 | -1,741.851 | -1,407.022 | -877.855 | -711.132 | -303.594 | 334.012 | 293.764 |
| Operating Income Ratio
| -1.754 | -2.155 | -2.104 | -1.582 | -1.183 | -0.952 | -2.706 | -1.057 | -0.88 | -1.04 | -0.763 | -0.416 | -0.325 | -0.114 | 0.104 | 0.101 |
| Total Other Income Expenses Net
| 111.609 | -7.84 | 84.309 | 242.622 | 89.463 | 219.603 | -323.533 | -834.13 | 46.737 | 76.73 | -164.059 | 536.268 | 95.798 | -75.026 | -27.222 | -38.949 |
| Income Before Tax
| -1,273.181 | -1,433.792 | -1,248.79 | -838.026 | -836.659 | -788.667 | -3,037.893 | -2,635.665 | -1,634.366 | -1,665.121 | -1,571.081 | -341.587 | -615.334 | -378.62 | 306.79 | 254.815 |
| Income Before Tax Ratio
| -1.657 | -2.167 | -1.971 | -1.227 | -1.068 | -0.745 | -3.043 | -1.547 | -0.856 | -0.994 | -0.852 | -0.162 | -0.281 | -0.142 | 0.096 | 0.088 |
| Income Tax Expense
| 3.813 | 4.158 | 5.301 | 5.369 | 5.353 | 6.64 | 10.651 | -31.979 | 8.831 | 47.199 | 9.64 | 6.832 | 9.654 | 163.906 | -131.765 | 8.942 |
| Net Income
| -1,276.994 | -1,437.95 | -1,254.091 | -843.395 | -842.012 | -795.307 | -3,048.545 | -2,603.685 | -1,643.198 | -1,712.32 | -1,580.722 | -348.419 | -624.988 | -542.527 | 438.556 | 245.873 |
| Net Income Ratio
| -1.662 | -2.174 | -1.979 | -1.235 | -1.075 | -0.751 | -3.054 | -1.528 | -0.861 | -1.023 | -0.857 | -0.165 | -0.285 | -0.203 | 0.137 | 0.085 |
| EPS
| -4.98 | -6.65 | -6.33 | -4.88 | -6.19 | -6.71 | -26.77 | -27.24 | -18.01 | -19.28 | -17.94 | -4.32 | -8.53 | -7.59 | 6.94 | 4.11 |
| EPS Diluted
| -4.98 | -6.65 | -6.33 | -4.88 | -6.19 | -6.71 | -26.77 | -27.24 | -18.01 | -19.28 | -17.94 | -4.32 | -8.53 | -7.59 | 6.69 | 4.11 |
| EBITDA
| -1,197.305 | -1,330.565 | -1,169.487 | -718.521 | -672.895 | -572.44 | -2,832.838 | -2,294.525 | -1,264.851 | -1,366.76 | -1,369.102 | -123.581 | -396.456 | -218.159 | 440.616 | 378.875 |
| EBITDA Ratio
| -1.558 | -2.011 | -1.846 | -1.052 | -0.859 | -0.541 | -2.838 | -1.347 | -0.662 | -0.816 | -0.742 | -0.059 | -0.181 | -0.082 | 0.138 | 0.131 |